Suchergebnisse - "Sun, Chaoyang"

PubPharm (9)

1

Comprehensive multi-omics analysis reveals WEE1 as a synergistic lethal target with hyperthermia through CDK1 super-activation

enthalten in: Nature communications | 2024

von Yang, X. | Hu, X. | Yin, J. | +15

2

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors

enthalten in: Journal for immunotherapy of cancer | 2023

von Fu, Y. | Yang, B. | Cui, Y. | +18

3

AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway

enthalten in: Cancer letters | 2022

von Liu, C. | Huang, Y. | Qin, T. | +23

4

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway

enthalten in: The Journal of experimental medicine | 2022

von Guo, E. | Xiao, R. | Wu, Y. | +18

5

Systems approach to rational combination therapy : PARP inhibitors

enthalten in: Biochemical Society transactions | 2020

von Sun, C. | Fang, Y. | Labrie, M. | +2

6

WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer

enthalten in: Cancer letters | 2020

von Sand, A. | Piacsek, M. | Donohoe, D. | +7

7

BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages

enthalten in: Frontiers in immunology | 2020

von Li, X. | Fu, Y. | Yang, B. | +10

8

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

enthalten in: Cancer cell | 2019

von Fang, Y. | McGrail, D. | Sun, C. | +24

CommentIn: Cancer Cell. 2019 Jun 10;35(6):821-822. - PMID 31185206

9

BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency

enthalten in: Cancer cell | 2018

von Sun, C. | Yin, J. | Fang, Y. | +17

1
[1]